Patient Demographics
| Patient no. | Age (y) | Sex | Sites of disease at study entry | Prior treatment (time from RAIT) | Baseline tumor markers | MBq/m290Y-hMN-14 (MBq) | ||
|---|---|---|---|---|---|---|---|---|
| CEA (ng/mL) | Calcitonin (pg/mL) | |||||||
| 1779 | 41 | M | Neck, lungs | S (11 mo) | 200 | ND | 740 (1,654) | |
| 1782 | 59 | M | Neck, lungs, bone | S (8 mo)XRT (3 sites) (2–5 mo) | 6,400 | 56,170 | 740 (1,610) | |
| 1785 | 51 | M | Neck, Med | S (5 mo) | 380 | 5,224 | 740 (1,606) | |
| 1789 | 70 | M | Neck, Med, lungs | S (5 mo) | 12 | 891 | 1,110 (2,642) | |
| 1790 | 32 | M | Med, liver | S (32 mo)Neck XRT (16 mo) | 1,800 | <14 | NT | |
| 1791 | 41 | F | Parotid gland | Multiple S (2–15 y) | 280 | 2,173 | 1,110 (2,253) | |
| 1796 | 70 | F | Thyroid, Med, liver | S (7 mo)Taxol/carboplatin (2 mo) | 1,180 | 49,411 | 1,110 (1,887) | |
| 1799 | 42 | M | Neck, Med | S (3 y)131I ablation + XRT (3 y) | 5.7 | 15,541 | 1,480 (3,034) | |
| 1812 | 16 | M | Neck, lungs | S (2 mo) | 240 | 51,194 | 1,480 (1,672) | |
| 1818 | 75 | M | Neck, bone | S (4 mo) | 3,650 | 69,780 | 1,480 (2,967) | |
| 1827 | 63 | F | Neck, Med | S (6 mo) | 4.6 | 4,784 | 1,850 (3,700) | |
| 1831 | 19 | F | Lungs, liver, bone | XRT (2 mo) | 156 | 5,114 | 1,850 (2,997) | |
| 1853 | 41 | M | Neck, lungs, abdomen, liver | None | 260 | 13,118 | 1,850 (3,193) | |
| 1887 | 71 | M | Neck, Med | S (1–12 y) | 33 | 1,572 | 1,850 (3,574) | |
| 1889 | 60 | M | Lungs, Med, liver | S (10 y)XRT (9 y) | 320 | 15,071 | 1,850 (3,563) | |
RAIT = radioimmunotherapy; S = surgery; ND = not done; XRT = external-beam therapy; Med = mediastinum; NT = not treated.